» Articles » PMID: 34830362

Structural Basis of Arrestin Selectivity for Active Phosphorylated G Protein-Coupled Receptors

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Nov 27
PMID 34830362
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Arrestins are a small family of proteins that bind G protein-coupled receptors (GPCRs). Arrestin binds to active phosphorylated GPCRs with higher affinity than to all other functional forms of the receptor, including inactive phosphorylated and active unphosphorylated. The selectivity of arrestins suggests that they must have two sensors, which detect receptor-attached phosphates and the active receptor conformation independently. Simultaneous engagement of both sensors enables arrestin transition into a high-affinity receptor-binding state. This transition involves a global conformational rearrangement that brings additional elements of the arrestin molecule, including the middle loop, in contact with a GPCR, thereby stabilizing the complex. Here, we review structural and mutagenesis data that identify these two sensors and additional receptor-binding elements within the arrestin molecule. While most data were obtained with the arrestin-1-rhodopsin pair, the evidence suggests that all arrestins use similar mechanisms to achieve preferential binding to active phosphorylated GPCRs.

Citing Articles

Arrestins: A Small Family of Multi-Functional Proteins.

Gurevich V Int J Mol Sci. 2024; 25(11).

PMID: 38892473 PMC: 11173308. DOI: 10.3390/ijms25116284.


-Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives.

Wess J, Oteng A, Rivera-Gonzalez O, Gurevich E, Gurevich V Pharmacol Rev. 2023; 75(5):854-884.

PMID: 37028945 PMC: 10441628. DOI: 10.1124/pharmrev.121.000302.


The allosterically modulated FFAR2 is transactivated by signals generated by other neutrophil GPCRs.

Lind S, Granberg K, Forsman H, Dahlgren C PLoS One. 2023; 18(4):e0268363.

PMID: 37022990 PMC: 10079109. DOI: 10.1371/journal.pone.0268363.


β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells.

Wang Z, Li Z, Bal G, Franke K, Zuberbier T, Babina M Front Allergy. 2022; 3:930233.

PMID: 35910860 PMC: 9337275. DOI: 10.3389/falgy.2022.930233.

References
1.
Coffa S, Breitman M, Spiller B, Gurevich V . A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding. Biochemistry. 2011; 50(32):6951-8. PMC: 3153575. DOI: 10.1021/bi200745k. View

2.
Gurevich V, Dion S, Onorato J, Ptasienski J, Kim C, Hosey M . Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors. J Biol Chem. 1995; 270(2):720-31. DOI: 10.1074/jbc.270.2.720. View

3.
Chen Q, Perry N, Vishnivetskiy S, Berndt S, Gilbert N, Zhuo Y . Structural basis of arrestin-3 activation and signaling. Nat Commun. 2017; 8(1):1427. PMC: 5681653. DOI: 10.1038/s41467-017-01218-8. View

4.
Hauser A, Attwood M, Rask-Andersen M, Schioth H, Gloriam D . Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017; 16(12):829-842. PMC: 6882681. DOI: 10.1038/nrd.2017.178. View

5.
Hanson S, Francis D, Vishnivetskiy S, Kolobova E, Hubbell W, Klug C . Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin. Proc Natl Acad Sci U S A. 2006; 103(13):4900-5. PMC: 1458767. DOI: 10.1073/pnas.0600733103. View